Addus HomeCare Corporation (Nasdaq: ADUS) — 2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. The filing is an annual report; it does not provide a clear standalone fourth-quarter results summary.
Business context
Addus provides in-home personal care, hospice and home health services, primarily to consumers eligible for both Medicare and Medicaid. At year-end, it operated in 22 states through approximately 219 offices and served about 91,000 consumers during the year. Personal care remains the largest business. Revenue is substantially funded by government programs and managed care organizations.
Key financial results
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Net service revenue | $1,058.7 million | $951.1 million | +11.3% |
| Gross profit / margin | $339.9 million / 32.1% | $299.7 million / 31.5% | Margin +0.6 percentage points |
| Operating income / margin | $91.0 million / 8.6% | $68.7 million / 7.2% | +32.3% |
| Net income / net margin | $62.5 million / 5.9% | $46.0 million / 4.7% | +35.8% |
| Diluted earnings per share | $3.83 | $2.84 | Increased |
| Adjusted EBITDA | $121.0 million | $101.5 million | +19.3% |
Adjusted EBITDA is a non-GAAP measure; the company cautions that it should be considered alongside GAAP results, not as a substitute.
- Revenue by segment: Personal care $794.7 million (+12.5%); hospice $207.2 million (+2.7%); home health $56.8 million (+32.5%).
- Segment operating income: Personal care $157.5 million versus $125.4 million; hospice $44.9 million versus $51.1 million; home health $7.0 million versus $2.8 million. Hospice margin pressure contrasts with improvement in the other segments.
- Cash flow: Operating activities generated $112.2 million, compared with $105.1 million. Investing used $119.2 million, primarily for acquisitions and $9.5 million of capital expenditures. Financing used $8.2 million.
- Cash and liquidity: Cash was $64.8 million, down from $80.0 million. The company reported $335.6 million available to borrow under its credit facility, after stated borrowing limits and letters of credit.
- Debt: Revolver borrowings were $126.4 million at a 7.21% interest rate, compared with $134.9 million at 6.13% at the prior year-end. The facility matures July 30, 2026; the company reported covenant compliance at December 31, 2023.
- Balance sheet: Total assets were $1.024 billion; total liabilities were $317.7 million. Goodwill was $663.0 million and intangible assets were $92.0 million. No goodwill or intangible impairment was recorded.
Material changes versus 2022
- Personal care revenue rose with an 8.2% increase in revenue per billable hour and 4.2% more billable hours. Personal care gross margin increased to 27.9% from 26.3%.
- Home health growth reflected the full-year contribution from Apple Home and the August 2023 acquisition of Tennessee Quality Care; its gross margin increased to 37.0% from 30.4%.
- Hospice gross margin fell to 46.8% from 50.0%, primarily reflecting higher direct employee wages, taxes and benefits. Hospice operating income declined 12.2% despite higher revenue.
- Two 2023 acquisitions were CareStaff, expanding personal care into Florida, and Tennessee Quality Care, expanding hospice and home health in Tennessee. Tennessee Quality Care’s purchase price was approximately $111.2 million; acquisitions completed in 2023 contributed $18.8 million of annual net service revenue.
- Net interest expense increased to $9.6 million from $8.6 million, attributed to higher average borrowings and interest rates. Cash declined while acquisition spending exceeded operating cash generation.
Outlook, commentary and risks
- No company-specific 2024 revenue or earnings guidance is provided in the supplied filing text. Management says cash on hand, operating cash flows and credit availability should fund anticipated needs for at least 12 months and the foreseeable future.
- Management identifies caregiver and clinical staffing shortages, wage inflation and limits on passing cost increases through to government reimbursement as ongoing pressures. Approximately 51.3% of employees were represented by unions.
- Revenue and receivables are concentrated geographically and by payor. Illinois generated 44.5% of 2023 revenue; the Illinois Department on Aging alone generated 20.9%. Its receivables rose to $29.8 million, and represented 25.8% of net accounts receivable. Company-wide days sales outstanding improved to 39 from 45 days, while Illinois Department on Aging DSO increased to 50 from 42 days.
- New York’s Consumer Directed Personal Assistance Program (CDPAP) contract award allowed Addus to resume new fee-for-service admissions in 2023. The program remains subject to potential state changes; it generated $40.7 million of 2023 revenue and $3.5 million of operating income.
- A proposed federal Medicaid rule would require at least 80% of certain Medicaid payments to be spent on direct-care-worker compensation if finalized as proposed. CMS submitted a final rule for review in January 2024; its contents were not yet known in the filing.
- Other important risks include changes in Medicare and Medicaid rates or eligibility, payment delays and audits, hospice Medicare payment caps, labor disputes, acquisition integration, variable-rate debt, and cyber and privacy incidents. A 100-basis-point increase in borrowing rates would have reduced 2023 net income by an estimated $1.0 million, or $0.06 per diluted share.
- Management said pending legal and administrative proceedings were not expected to materially affect financial position or results. The company recorded a $0.8 million liability related to the Medicare hospice aggregate cap at year-end.
- PwC issued an unqualified opinion on the financial statements and internal control over financial reporting. Management also concluded controls were effective, while acquisitions completed in 2023 were excluded from the internal-control assessment.
Most important facts for investors to verify
- Whether personal care growth and margin gains persist as wage costs rise, and whether reimbursement increases keep pace.
- Whether hospice margins recover, given the 2023 decline, staffing costs and the reporting unit’s disclosed 20% goodwill impairment headroom.
- Illinois Department on Aging reimbursement, payment timing and receivable collection trends, given the concentration in revenue and year-end receivables.
- The final terms and implementation effects of the Medicaid access rule, and any changes to New York CDPAP participation or economics.
- Integration and returns from Tennessee Quality Care and other acquisitions, including the impact on debt, interest expense and available borrowing capacity.